1.45Open1.45Pre Close0 Volume182 Open Interest10.00Strike Price0.00Turnover83.88%IV4.26%PremiumAug 16, 2024Expiry Date1.07Intrinsic Value100Multiplier25DDays to Expiry0.38Extrinsic Value100Contract SizeAmericanOptions Type-0.6522Delta0.1894Gamma6.16Leverage Ratio-0.0136Theta-0.0042Rho-4.02Eff Leverage0.0087Vega
EyePoint Pharmaceuticals Stock Discussion
NEWS
EyePoint Pharmaceuticals Trial of Duravyu in Diabetic Eye Disease Fails to Meet Primary Endpoint
Larger Image: tradingview.com...
$EyePoint Pharmaceuticals(EYPT.US)$
$EyePoint Pharmaceuticals(EYPT.US)$
$Adverum Biotechnologies(ADVM.US)$
$Regenxbio(RGNX.US)$
$4D Molecular Therapeutics(FDMT.US)$
$Kodiak Sciences(KOD.US)$
📊⚡️📊
No comment yet